| 22039520
|
LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs. |
PLoS One |
2011 |
Lai Y;Adhikarakunnathu S;Bhardwaj K;Ranjith-Kumar CT;Wen Y;Jordan JL;Wu LH;Dragnea B;San Mateo L;Kao CC |
View
More |
| 23024024
|
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. |
Am J Respir Crit Care Med |
2012 |
Mallia P;Footitt J;Sotero R;Jepson A;Contoli M;Trujillo-Torralbo MB;Kebadze T;Aniscenko J;Oleszkiewicz G;Gray K;Message SD;Ito K;Barnes PJ;Adcock IM;Papi A;Stanciu LA;Elkin SL;Kon OM;Johnson M;Johnston SL |
View
More |
| 23204370
|
Chance favors the prepared mind. |
Am J Respir Crit Care Med |
2012 |
Sethi S |
View
More |
| 24673807
|
CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations. |
Clin Exp Allergy |
2014 |
Rohde G;Message SD;Haas JJ;Kebadze T;Parker H;Laza-Stanca V;Khaitov MR;Kon OM;Stanciu LA;Mallia P;Edwards MR;Johnston SL |
View
More |
| 26585423
|
Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37. |
Eur Respir J |
2016 |
Schogler A;Muster RJ;Kieninger E;Casaulta C;Tapparel C;Jung A;Moeller A;Geiser T;Regamey N;Alves MP |
View
More |
| 27838350
|
Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro. |
Antiviral Res |
2017 |
Telcian AG;Zdrenghea MT;Edwards MR;Laza-Stanca V;Mallia P;Johnston SL;Stanciu LA |
View
More |
| 28541502
|
Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology. |
Clin Infect Dis |
2017 |
Mansbach JM;Hasegawa K;Ajami NJ;Petrosino JF;Piedra PA;Tierney CN;Espinola JA;Camargo CA |
View
More |
| 28764966
|
Cathelicidins display conserved direct antiviral activity towards rhinovirus. |
Peptides |
2017 |
Sousa FH;Casanova V;Findlay F;Stevens C;Svoboda P;Pohl J;Proudfoot L;Barlow PG |
View
More |
| 28814602
|
Carbon Nanoparticles Inhibit the Antimicrobial Activities of the Human Cathelicidin LL-37 through Structural Alteration. |
J Immunol |
2017 |
Findlay F;Pohl J;Svoboda P;Shakamuri P;McLean K;Inglis NF;Proudfoot L;Barlow PG |
View
More |
| 31054799
|
The impact of viral bronchiolitis phenotyping: Is it time to consider phenotype-specific responses to individualize pharmacological management? |
Paediatr Respir Rev |
2020 |
Rodriguez-Martinez CE;Castro-Rodriguez JA;Nino G;Midulla F |
View
More |
